Les principaux facteurs incluent l'âge avancé, le sexe féminin et des antécédents familiaux.
Facteurs de risqueÂge avancéAntécédents familiaux
#2
Le tabagisme est-il un facteur de risque ?
Oui, le tabagisme est associé à un risque accru d'artérite temporale.
TabagismeFacteurs de risqueArtérite
#3
Les maladies auto-immunes augmentent-elles le risque ?
Oui, certaines maladies auto-immunes peuvent augmenter le risque d'artérite temporale.
Maladies auto-immunesFacteurs de risqueArtérite
#4
L'inflammation chronique est-elle un facteur de risque ?
Oui, l'inflammation chronique dans le corps peut contribuer au développement de l'artérite temporale.
Inflammation chroniqueFacteurs de risqueArtérite
#5
Les antécédents de migraines influencent-ils le risque ?
Des antécédents de migraines peuvent être associés à un risque accru d'artérite temporale.
MigrainesFacteurs de risqueArtérite
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Artères temporales : Questions médicales les plus fréquentes",
"headline": "Artères temporales : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Artères temporales : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-08-05",
"dateModified": "2025-05-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Artères temporales"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Artères cérébrales",
"url": "https://questionsmedicales.fr/mesh/D002536",
"about": {
"@type": "MedicalCondition",
"name": "Artères cérébrales",
"code": {
"@type": "MedicalCode",
"code": "D002536",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A07.015.114.228"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Artères temporales",
"alternateName": "Temporal Arteries",
"code": {
"@type": "MedicalCode",
"code": "D013699",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Tugba Morali Guler",
"url": "https://questionsmedicales.fr/author/Tugba%20Morali%20Guler",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurosurgery, Karabuk University, School of Medicine, Karabuk."
}
},
{
"@type": "Person",
"name": "Yahya Efe Guner",
"url": "https://questionsmedicales.fr/author/Yahya%20Efe%20Guner",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurosurgery, Yuksek Ihtisas University, School of Medicine."
}
},
{
"@type": "Person",
"name": "Ali Can Korkmaz",
"url": "https://questionsmedicales.fr/author/Ali%20Can%20Korkmaz",
"affiliation": {
"@type": "Organization",
"name": "Department of Anatomy."
}
},
{
"@type": "Person",
"name": "Yigit Gungor",
"url": "https://questionsmedicales.fr/author/Yigit%20Gungor",
"affiliation": {
"@type": "Organization",
"name": "Department of Anatomy."
}
},
{
"@type": "Person",
"name": "Yagiz Emre Sayaci",
"url": "https://questionsmedicales.fr/author/Yagiz%20Emre%20Sayaci",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurosurgery."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "AUCReshaping: improved sensitivity at high-specificity.",
"datePublished": "2023-11-30",
"url": "https://questionsmedicales.fr/article/38036602",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-023-48482-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Meta-analysis assessing the sensitivity and specificity of",
"datePublished": "2023-03-18",
"url": "https://questionsmedicales.fr/article/36934977",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ahj.2023.03.004"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sensitivity and specificity of Varian Halcyon's portal dosimetry for plan-specific pre-treatment QA.",
"datePublished": "2023-04-22",
"url": "https://questionsmedicales.fr/article/37086428",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/acm2.14001"
}
},
{
"@type": "ScholarlyArticle",
"name": "Specific recognition and sensitive quantification of mRNA splice variants",
"datePublished": "2023-11-06",
"url": "https://questionsmedicales.fr/article/37818948",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1039/d3an01382k"
}
},
{
"@type": "ScholarlyArticle",
"name": "Estimating stage-specific sensitivity for cancer screening tests.",
"datePublished": "2023-02-03",
"url": "https://questionsmedicales.fr/article/36734139",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/09691413231154801"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Système cardiovasculaire",
"item": "https://questionsmedicales.fr/mesh/D002319"
},
{
"@type": "ListItem",
"position": 3,
"name": "Vaisseaux sanguins",
"item": "https://questionsmedicales.fr/mesh/D001808"
},
{
"@type": "ListItem",
"position": 4,
"name": "Artères",
"item": "https://questionsmedicales.fr/mesh/D001158"
},
{
"@type": "ListItem",
"position": 5,
"name": "Artères cérébrales",
"item": "https://questionsmedicales.fr/mesh/D002536"
},
{
"@type": "ListItem",
"position": 6,
"name": "Artères temporales",
"item": "https://questionsmedicales.fr/mesh/D013699"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Artères temporales - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Artères temporales",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Artères temporales",
"description": "Comment diagnostiquer une artérite temporale ?\nQuels tests sont utilisés pour évaluer les artères temporales ?\nQuels signes indiquent une inflammation des artères temporales ?\nQuel rôle joue la vitesse de sédimentation dans le diagnostic ?\nQuand faut-il suspecter une artérite temporale ?",
"url": "https://questionsmedicales.fr/mesh/D013699?mesh_terms=Sensitivity+and+Specificity#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Artères temporales",
"description": "Quels sont les symptômes courants de l'artérite temporale ?\nComment se manifeste la douleur liée aux artères temporales ?\nLes troubles de la vision sont-ils fréquents ?\nY a-t-il des symptômes systémiques associés ?\nComment la douleur à la mâchoire est-elle liée à l'artérite temporale ?",
"url": "https://questionsmedicales.fr/mesh/D013699?mesh_terms=Sensitivity+and+Specificity#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Artères temporales",
"description": "Peut-on prévenir l'artérite temporale ?\nQuels modes de vie peuvent aider à réduire les risques ?\nLes facteurs de risque peuvent-ils être modifiés ?\nLe suivi médical est-il important ?\nLes vaccinations peuvent-elles aider ?",
"url": "https://questionsmedicales.fr/mesh/D013699?mesh_terms=Sensitivity+and+Specificity#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Artères temporales",
"description": "Quel est le traitement principal de l'artérite temporale ?\nCombien de temps dure le traitement par corticostéroïdes ?\nDes médicaments supplémentaires sont-ils nécessaires ?\nComment surveiller l'efficacité du traitement ?\nY a-t-il des effets secondaires des corticostéroïdes ?",
"url": "https://questionsmedicales.fr/mesh/D013699?mesh_terms=Sensitivity+and+Specificity#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Artères temporales",
"description": "Quelles sont les complications possibles de l'artérite temporale ?\nComment la perte de vision se produit-elle ?\nLes AVC sont-ils fréquents avec l'artérite temporale ?\nComment prévenir les complications ?\nY a-t-il des complications à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D013699?mesh_terms=Sensitivity+and+Specificity#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Artères temporales",
"description": "Quels sont les principaux facteurs de risque ?\nLe tabagisme est-il un facteur de risque ?\nLes maladies auto-immunes augmentent-elles le risque ?\nL'inflammation chronique est-elle un facteur de risque ?\nLes antécédents de migraines influencent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D013699?mesh_terms=Sensitivity+and+Specificity#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une artérite temporale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic se fait par une évaluation clinique et une biopsie de l'artère temporale."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les artères temporales ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'échographie Doppler et l'IRM peuvent être utilisés pour évaluer les artères temporales."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une inflammation des artères temporales ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs à la tête, une sensibilité du cuir chevelu et des troubles visuels peuvent indiquer une inflammation."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la vitesse de sédimentation dans le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une vitesse de sédimentation élevée peut indiquer une inflammation associée à l'artérite temporale."
}
},
{
"@type": "Question",
"name": "Quand faut-il suspecter une artérite temporale ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il faut suspecter une artérite temporale en cas de céphalées persistantes chez les personnes âgées."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de l'artérite temporale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des maux de tête, une douleur à la mâchoire et des troubles visuels."
}
},
{
"@type": "Question",
"name": "Comment se manifeste la douleur liée aux artères temporales ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "La douleur est souvent localisée sur le côté de la tête et peut être intense et pulsatile."
}
},
{
"@type": "Question",
"name": "Les troubles de la vision sont-ils fréquents ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles de la vision, comme la perte de vision temporaire, peuvent survenir."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes systémiques associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fièvre, la fatigue et la perte de poids peuvent également être présents."
}
},
{
"@type": "Question",
"name": "Comment la douleur à la mâchoire est-elle liée à l'artérite temporale ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "La douleur à la mâchoire, surtout lors de la mastication, peut indiquer une atteinte des artères temporales."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir l'artérite temporale ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique, mais un suivi médical régulier est conseillé."
}
},
{
"@type": "Question",
"name": "Quels modes de vie peuvent aider à réduire les risques ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Adopter un mode de vie sain, avec une alimentation équilibrée et de l'exercice, peut aider."
}
},
{
"@type": "Question",
"name": "Les facteurs de risque peuvent-ils être modifiés ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains facteurs comme le tabagisme et l'hypertension peuvent être modifiés pour réduire les risques."
}
},
{
"@type": "Question",
"name": "Le suivi médical est-il important ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi médical régulier permet de détecter précocement les signes d'inflammation."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles aider ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccinations contre certaines infections peuvent indirectement réduire les risques d'inflammation."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal de l'artérite temporale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est l'administration de corticostéroïdes pour réduire l'inflammation."
}
},
{
"@type": "Question",
"name": "Combien de temps dure le traitement par corticostéroïdes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut durer plusieurs mois, avec un suivi régulier pour ajuster la dose."
}
},
{
"@type": "Question",
"name": "Des médicaments supplémentaires sont-ils nécessaires ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments immunosuppresseurs peuvent être ajoutés si les corticostéroïdes ne suffisent pas."
}
},
{
"@type": "Question",
"name": "Comment surveiller l'efficacité du traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La surveillance se fait par des examens cliniques et des tests sanguins réguliers."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires des corticostéroïdes ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets secondaires comme la prise de poids, l'hypertension et l'ostéoporose peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de l'artérite temporale ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la perte de vision permanente et les accidents vasculaires cérébraux."
}
},
{
"@type": "Question",
"name": "Comment la perte de vision se produit-elle ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "La perte de vision peut survenir en raison d'une ischémie des artères ophtalmiques."
}
},
{
"@type": "Question",
"name": "Les AVC sont-ils fréquents avec l'artérite temporale ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les AVC peuvent survenir en raison de l'inflammation des vaisseaux sanguins."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement précoce et un suivi régulier sont essentiels pour prévenir les complications."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications à long terme ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications à long terme peuvent inclure des douleurs chroniques et des troubles cognitifs."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent l'âge avancé, le sexe féminin et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est associé à un risque accru d'artérite temporale."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies auto-immunes peuvent augmenter le risque d'artérite temporale."
}
},
{
"@type": "Question",
"name": "L'inflammation chronique est-elle un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'inflammation chronique dans le corps peut contribuer au développement de l'artérite temporale."
}
},
{
"@type": "Question",
"name": "Les antécédents de migraines influencent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antécédents de migraines peuvent être associés à un risque accru d'artérite temporale."
}
}
]
}
]
}
Department of Plastic and Reconstructive Surgery, Guangdong Second Provincial General Hospital, 466 Middle Xin Gang Road, Guangzhou City, 510317, Guangdong Province, People's Republic of China.
Department of Plastic and Reconstructive Surgery, Guangdong Second Provincial General Hospital, 466 Middle Xin Gang Road, Guangzhou City, 510317, Guangdong Province, People's Republic of China.
Department of Plastic and Reconstructive Surgery, Guangdong Second Provincial General Hospital, 466 Middle Xin Gang Road, Guangzhou City, 510317, Guangdong Province, People's Republic of China.
Department of Plastic and Reconstructive Surgery, Guangdong Second Provincial General Hospital, 466 Middle Xin Gang Road, Guangzhou City, 510317, Guangdong Province, People's Republic of China.
Department of Plastic and Reconstructive Surgery, Guangdong Second Provincial General Hospital, 466 Middle Xin Gang Road, Guangzhou City, 510317, Guangdong Province, People's Republic of China. luoshk@gd2h.org.cn.
Division in Anatomy and Developmental Biology, Department of Oral Biology, Human Identification Research Institute, BK21 FOUR Project, Yonsei University College of Dentistry, Seoul, South Korea.
Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)
Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)
Department of Neurological Surgery, University of California San Francisco, 505 Parnassus Ave, San Francisco, CA, 94143, USA. william.rutledge@ucsf.edu.
Division of Vascular Medicine, Medicial Clinic and Policlinic IV, Hospital of the Ludwig Maximilians University, Munich, Germany michael.czihal@med.uni-muenchen.de.
The evaluation of deep-learning (DL) systems typically relies on the Area under the Receiver-Operating-Curve (AU-ROC) as a performance metric. However, AU-ROC, in its holistic form, does not sufficien...
The use of...
To estimate the summary sensitivity and specificity of...
Studies were included if PET/CT was performed for suspicion of PVE and IPD of both the PET/CT result and final diagnosis defined by a gold-standard assessment was available. There were 3 possible fina...
Seventeen studies were included with IPD available for 537 patients (from 538 scans). The summary sensitivity and specificity were 85% (95% CI 74.2%-91.8%) and 86.5% (95% CI 75.8%-92.9%) respectively ...
Developed as a plan-specific pre-treatment QA tool, Varian portal dosimetry promises a fast, high-resolution, and integrated QA solution. In this study, the agreement between predicted fluence and mea...
All patient plans and the corresponding verification plans were generated within the Eclipse treatment planning system. Four representative plans of different treatment sites (prostate, prostate with ...
Predicted and acquired portal dosimetry fluences demonstrated a high agreement evident by average gamma passing rates for the clinical patient plans of 99.90%, 96.64%, and 91.87% for γ...
Owing to the high achievable spatial resolution, portal dosimetry at the Halcyon can reliably be deployed as plan-specific pre-treatment QA tool to screen for errors. It is recommended to support the ...
Specific recognition and sensitive quantification of mRNA alternative splice variants have been a necessity for exploring the regulatory mechanism of RNA splicing and revealing the association between...
When evaluating potential new cancer screening modalities, estimating sensitivity, especially for early-stage cases, is critical. There are methods to approximate stage-specific sensitivity in asympto...
We fit natural history models to lung and ovarian cancer screening data that permitted estimation of stage-specific (early/late) true sensitivity, defined as the probability subjects screened in the g...
Stage-specific true sensitivities estimated by the lung cancer natural history model were 47% (early) and 63% (late). Simulation results for the prospective setting gave estimated sensitivities of 81%...
Existing methods for approximating stage-specific sensitivity in both prospective and retrospective scenarios are unsatisfactory; improvements are needed before they can be considered to be reliable....
Recombinant proteins in complex solutions are typically detected with tag-specific antibodies in Western blots. Here we describe an antibody-free alternative in which tagged proteins are detected dire...
Children with cancer often present with general and nonspecific symptoms leading to initial diagnostic workup inclusive of clinical imaging. Various sequences of magnetic resonance imaging (MRI) are b...
Enzyme-linked immunosorbent assays (ELISAs) are a cornerstone of modern molecular detection, but the technique still faces notable challenges. One of the biggest problems is discriminating true signal...
To evaluate the sensitivity and specificity of the ABCD progression display for keratoconus progression....
Data was collected from patients that underwent at least two Pentacam assessments 6 months apart. Sensitivity and specificity were calculated for the ABCD progression display. Progression was defined ...
Thirty eyes were evaluated over a median time of 10.3 months. Progression by criterion 1 resulted in a sensitivity of 61.9% and specificity of 88.9%. Progression by criterion 2 resulted in higher sens...
The ABCD progression display can assess keratoconus progression with high sensitivity and specificity, thus assisting the patients' decision-making process. The D parameter did not contribute to the s...
To systematically evaluate the evidence for the reliability, sensitivity and specificity of existing measures of vowel-initial voice onset....
A literature search was conducted across electronic databases for published studies (MEDLINE, EMBASE, Scopus, Web of Science, CINAHL, PubMed Central, IEEE Xplore) and grey literature (ProQuest for unp...
The search retrieved 6,983 records. Titles and abstracts were screened against the inclusion criteria by two independent reviewers, with a third reviewer responsible for conflict resolution. Thirty-fi...
A range of vowel-initial voice onset measurements have been applied throughout the literature, however, there is a lack of evidence regarding their sensitivity, specificity and reliability in the dete...